Proquin XR News
Depomed Reports Preliminary 2007 Year End Financial Results - PharmaLive.com (press release)
... and a $5.0 million one-time gain from the termination of the company's license and supply agreements with Esprit Pharma for ProQuin(R) XR (ciprofloxacin ...
Depomed Swings To Profit In Q4 On One Time Gain - Trading Markets (press release)
... one-time gain from the termination of the company's license and supply agreements with Esprit Pharma for ProQuin XR in the third quarter of 2007. ...
Depomed Reports Preliminary 2007 Year End Financial Results - Business Wire (press release)
... and a $5.0 million one-time gain from the termination of the company’s license and supply agreements with Esprit Pharma for ProQuin ® XR (ciprofloxacin ...
Terminated deals boost Depomed profit - Bizjournals.com
... $2.5 million in royalties and a $5 million one-time gain from the ending of license and supply deals with Esprit Pharma over the drug ProQuin XR. ...
Etrials Worldwide Q4 Loss Widens [ETWC] - RTT News
... one-time gain from the termination of the company's license and supply agreements with Esprit Pharma for ProQuin XR in the third quarter of 2007. ...
Depomed to Announce Fourth Quarter and Year-End 2007 Financial ... - Earthtimes
Proquin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Market Review: Global Market Review for Depomed, Inc. - Trading Markets (press release)
ProQuin XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Watson Announces Silodosin NDA Accepted for Filing by FDA for the ... - FOXBusiness
... Trelstar(R) LA; Trelstar(R) Depot; Androderm(R); AndroGel(R), under a co-promotion agreement with Solvay Pharmaceuticals, Inc.; and ProQuin(R) XR, ...
The SI Report: Progress Review for Depomed, Inc. - Trading Markets (press release)
Proquin XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Depomed Reports Positive Efficacy Data From a Phase 2 Trial of ... - Business Wire (press release)
Proquin ® XR (ciprofloxacin hydrochloride) extended release tablets are approved in the United States for the once-daily treatment of uncomplicated urinary ...
Proquin XR RSS Feed